These data were not specific to one AML or MM cell line as similar results were observed with other CD123+ AML (MOLM-13 and OCI-AML5) and BCMA+ MM cell lines (RPMI-8226 and MM.1S) (Supplementary Fig. 2C, D). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.